gold has been researched along with Parkinson Disease in 33 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (3.03) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 12 (36.36) | 24.3611 |
2020's | 20 (60.61) | 2.80 |
Authors | Studies |
---|---|
Barbir, R; Frkanec, R; Hall, CR; Kalčec, N; Peranić, N; Sani, MA; Separovic, F; Smith, TA; Vinković Vrček, I | 1 |
Ahmadalipour, A; Aminabad, ED; Feizi, MAH; Hasanzadeh, M; Mahmoudi, T; Mobed, A; Safaralizadeh, R | 1 |
Furkan, M; Khan, MS; Khan, RH; Kumar, A; Nami, SAA; Parveen, M; Rehman, R | 1 |
Chang, Y; Han, YE; Im, H; Kang, H; Lee, S; Lee, W; Lee, YK; Oh, SJ; Park, HJ; Park, S; Ryu, H; Seol, Y; Shim, HS; Yoo, J | 1 |
Carneiro, P; Delerue-Matos, C; Loureiro, JA; Morais, S; Pereira, MDC | 1 |
Chen, H; Chen, J; Chen, Q; Hu, R; Hu, X; Liu, Y; Lu, Y; Zhu, H | 1 |
Chen, G; Deng, J; Ge, S; Gu, Y; Li, G; Mao, Y; Zhou, X | 1 |
Liu, RR; Shao, HP; Wang, TH; Zhai, HL; Zhu, M | 1 |
Bera, K; Kundu, S; Maiti, NC; Maity, A; Mandal, AK; Misra, R; Mondal, A; Pal, U; Shome, G; Singh, A | 1 |
Cao, X; Chen, M; Ge, S; Mao, H; Wang, Y | 1 |
Jiang, Y; Ling, L; Liu, T; Liu, Y; Mohan, SK; Seshadri, VDD; Xue, J | 1 |
Anbu, P; Dong, X; Fan, H; Feng, S; Gopinath, SCB; Huang, X; Li, J; Wang, S; Xin, T; Yang, F; Yang, Y; Zhang, R | 1 |
Gao, G; Gao, X; He, M; Hu, J; Sun, T; Xu, H; Yin, Q | 1 |
Lin, W; McClain, SM; Murphy, CJ; Ojoawo, AM; Rienstra, CM | 1 |
Chang, J; Chen, M; Gong, X; Li, H; Luo, R; Peng, W; Qin, Y; Shi, Z; Zhou, D | 1 |
Correa, MEAB; da Silva Abel, J; da Silva Córneo, E; de Bem Silveira, G; Feuser, PE; Luiz, GP; Machado-de-Ávila, RA; Scussel, R; Silveira, PCL | 1 |
Guan, YQ; Li, CH; Li, M; Li, Y; Liu, L; Wang, Z; Xu, M; You, R; Zeng, Z; Zhang, Y | 1 |
Biswas, SC; Chattopadhyay, K; Mahapatra, A; Sarkar, S | 1 |
Adam, H; Arshad, MKM; Gopinath, SCB; Hashim, U; Parmin, NA | 1 |
Sezgintürk, MK; Sonuç Karaboğa, MN | 2 |
Ahmadalipour, A; Koohkan, G; Mobed, A; Razavi, S; Shakouri, SK | 1 |
Aghili, Z; Divsalar, A; Nasirizadeh, N; Shoeibi, S; Yaghmaei, P | 1 |
Chen, W; Chen, X; Guan, YQ; Hu, K; Li, CH; Li, J; Ye, J; Yin, L; Zhang, L; Zhang, Y | 1 |
Bals, S; Castilla, J; Claes, N; Cortajarena, AL; Eraña, H; Kumar, J; Liz-Marzán, LM; López-Martínez, E; Martín, VF; Solís, DM | 1 |
Cheng, C; Ji, D; Liu, J; Liu, Q; Liu, Z; Low, SS; Shi, Z; Xu, H; Xu, N; Yu, X; Zhang, T; Zhu, J | 1 |
Chen, R; Gao, G; He, M; Li, J; Sun, T; Wang, L | 1 |
Alvarez, YD; Fauerbach, JA; Jares-Erijman, EA; Jovin, TM; Pellegrotti, JV; Stefani, FD | 1 |
An, JH; Choi, DK; Choi, JW; Lee, KJ | 1 |
Cheng, H; Davis, JJ; Lehr, J; Patil, AV; Xu, Q | 1 |
Fan, C; Hu, J; Li, D; Li, K; Qin, W; Shi, J; Wang, K; Xu, Y; Zhou, Z; Zhu, B | 1 |
An, Y; Chen, H; Jiang, X; Jin, L; Tang, L; Wang, C; Yang, M; Zhang, S; Zhang, W | 1 |
Mindadse, AA; Tschikowani, TI | 1 |
1 review(s) available for gold and Parkinson Disease
Article | Year |
---|---|
Biosensors in Parkinson's disease.
Topics: Aged; alpha-Synuclein; Biosensing Techniques; Gold; Humans; Metal Nanoparticles; Nanotubes, Carbon; Neurodegenerative Diseases; Parkinson Disease; Quality of Life | 2021 |
32 other study(ies) available for gold and Parkinson Disease
Article | Year |
---|---|
Spectroscopic study of L-DOPA and dopamine binding on novel gold nanoparticles towards more efficient drug-delivery system for Parkinson's disease.
Topics: Dopamine; Drug Delivery Systems; Gold; Humans; Levodopa; Metal Nanoparticles; Parkinson Disease | 2022 |
Sensitive electrochemical recognition of α-synuclein protein in human plasma samples using bioconjugated gold nanoparticles: An innovative immuno-platform to assist in the early stage identification of Parkinson's disease by biosensor technology.
Topics: alpha-Synuclein; Antibodies; Biosensing Techniques; Electrochemical Techniques; Gold; Humans; Immunoassay; Limit of Detection; Metal Nanoparticles; Parkinson Disease | 2023 |
Comparative study of biogenically synthesized silver and gold nanoparticles of Acacia auriculiformis leaves and their efficacy against Alzheimer's and Parkinson's disease.
Topics: Acacia; Alzheimer Disease; Anti-Bacterial Agents; Gold; Metal Nanoparticles; Parkinson Disease; Plant Extracts; Plant Leaves; Silver; Spectroscopy, Fourier Transform Infrared; X-Ray Diffraction | 2022 |
Elongated nanoporous Au networks improve somatic cell direct conversion into induced dopaminergic neurons for Parkinson's disease therapy.
Topics: Antioxidants; Cellular Reprogramming; Dopaminergic Neurons; Gold; Humans; Nanopores; Parkinson Disease | 2022 |
Nanostructured label-free electrochemical immunosensor for detection of a Parkinson's disease biomarker.
Topics: alpha-Synuclein; Biomarkers; Biosensing Techniques; Electrochemical Techniques; Electrodes; Gold; Humans; Immunoassay; Limit of Detection; Metal Nanoparticles; Nanotubes, Carbon; Parkinson Disease | 2023 |
Nanozyme-based cascade SPR signal amplification for immunosensing of nitrated alpha-synuclein.
Topics: alpha-Synuclein; Biomarkers; Biosensing Techniques; Gold; Humans; Immunoassay; Metal Nanoparticles; Nitrates; Parkinson Disease; Surface Plasmon Resonance | 2022 |
Multiplex signal amplification strategy-based early-stage diagnosis of Parkinson's disease on a SERS-enabled LoC system.
Topics: Animals; Biosensing Techniques; DNA; Gold; Limit of Detection; Metal Nanoparticles; Mice; MicroRNAs; Nucleic Acid Amplification Techniques; Parkinson Disease; Reproducibility of Results; Spectrum Analysis, Raman | 2023 |
Inhibitory mechanism of n-MTAB AuNPs for α-synuclein aggregation.
Topics: alpha-Synuclein; Bromides; Gold; Humans; Metal Nanoparticles; Parkinson Disease | 2023 |
Naringenin-Functionalized Gold Nanoparticles and Their Role in α-Synuclein Stabilization.
Topics: alpha-Synuclein; Amyloid; Gold; Humans; Metal Nanoparticles; Parkinson Disease; Spectroscopy, Fourier Transform Infrared | 2023 |
LoC-SERS Platform Integrated with the Signal Amplification Strategy toward Parkinson's Disease Diagnosis.
Topics: Animals; Biomarkers; Gold; Limit of Detection; Metal Nanoparticles; Mice; Parkinson Disease; Reproducibility of Results; Silicon; Spectrum Analysis, Raman; tau Proteins | 2023 |
Neuroprotective effect of biosynthesised gold nanoparticles synthesised from root extract of Paeonia moutan against Parkinson disease - In vitro &In vivo model.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Cell Line; Cell Survival; Cytokines; Gold; Green Chemistry Technology; Lipopolysaccharides; Male; Metal Nanoparticles; Mice; Mice, Inbred C57BL; Microglia; Neuroprotective Agents; Nitric Oxide; Paeonia; Parkinson Disease; Plant Extracts; Plant Roots | 2019 |
Gold-nanourchin seeded single-walled carbon nanotube on voltammetry sensor for diagnosing neurogenerative Parkinson's disease.
Topics: alpha-Synuclein; Antibodies, Immobilized; Biomarkers; Electrochemical Techniques; Electrodes; Gold; Immunoassay; Limit of Detection; Metal Nanoparticles; Nanotubes, Carbon; Parkinson Disease; Reproducibility of Results | 2020 |
Optimal route of gold nanoclusters administration in mice targeting Parkinson's disease.
Topics: Animals; Blood-Brain Barrier; Gold; Metal Nanoparticles; Mice; Parkinson Disease; Tissue Distribution | 2020 |
Interaction of Alpha-Synuclein and Its Mutants with Rigid Lipid Vesicle Mimics of Varying Surface Curvature.
Topics: alpha-Synuclein; Gold; Humans; Lipids; Metal Nanoparticles; Mutation; Parkinson Disease | 2020 |
High fluorescence quenching probe-based reverse fluorescence enhancement LFTS coupling with IS-primer amplification reaction for the rapid and sensitive Parkinson Disease-associated MicroRNA detection.
Topics: Biosensing Techniques; Gold; Humans; Metal Nanoparticles; MicroRNAs; Parkinson Disease | 2020 |
Effects of gold nanoparticles administration through behavioral and oxidative parameters in animal model of Parkinson's disease.
Topics: Animals; Disease Models, Animal; Gold; Male; Metal Nanoparticles; Mice; Mice, Inbred C57BL; Oxidative Stress; Parkinson Disease; Particle Size | 2020 |
Actively targeted gold nanoparticle composites improve behavior and cognitive impairment in Parkinson's disease mice.
Topics: Animals; Cognitive Dysfunction; Disease Models, Animal; Gold; Metal Nanoparticles; Mice; Mice, Inbred C57BL; Parkinson Disease; Substantia Nigra | 2020 |
Modulation of α-Synuclein Fibrillation by Ultrasmall and Biocompatible Gold Nanoclusters.
Topics: alpha-Synuclein; Animals; Blood-Brain Barrier; Gold; Mice; Neurons; Parkinson Disease | 2020 |
Distinguishing normal and aggregated alpha-synuclein interaction on gold nanorod incorporated zinc oxide nanocomposite by electrochemical technique.
Topics: alpha-Synuclein; Aluminum; Electrochemical Techniques; Electrodes; Gold; Humans; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Nanocomposites; Nanotubes; Parkinson Disease; Particle Size; Protein Aggregates; Sensitivity and Specificity; Surface Properties; Zinc Oxide | 2021 |
A nano-composite based regenerative neuro biosensor sensitive to Parkinsonism-associated protein DJ-1/Park7 in cerebrospinal fluid and saliva.
Topics: Biosensing Techniques; Electrochemistry; Gold; Humans; Metal Nanoparticles; Nanocomposites; Nanotubes, Carbon; Parkinson Disease; Protein Deglycase DJ-1; Saliva | 2021 |
A highly sensitive miR-195 nanobiosensor for early detection of Parkinson's disease.
Topics: Biosensing Techniques; Early Diagnosis; Electrochemistry; Gold; Graphite; Humans; Limit of Detection; MicroRNAs; Models, Molecular; Nanotechnology; Nanowires; Nucleic Acid Conformation; Nucleic Acid Hybridization; Oxides; Parkinson Disease | 2018 |
Neuroprotective effect of gold nanoparticles composites in Parkinson's disease model.
Topics: Animals; Gold; Humans; Metal Nanoparticles; Mice; Nerve Growth Factor; Neuroprotective Agents; Parkinson Disease; Plasmids | 2018 |
Detection of amyloid fibrils in Parkinson's disease using plasmonic chirality.
Topics: Aged; alpha-Synuclein; Amyloid; Brain; Circular Dichroism; Cryoelectron Microscopy; Electron Microscope Tomography; Female; Gold; Humans; Lewy Bodies; Nanotubes; Parkinson Disease; Prions; Surface Plasmon Resonance | 2018 |
Smartphone-based differential pulse amperometry system for real-time monitoring of levodopa with carbon nanotubes and gold nanoparticles modified screen-printing electrodes.
Topics: Antiparkinson Agents; Biosensing Techniques; Drug Monitoring; Electrochemical Techniques; Electrodes; Equipment Design; Gold; Humans; Levodopa; Limit of Detection; Metal Nanoparticles; Models, Molecular; Nanotubes, Carbon; Parkinson Disease; Smartphone | 2019 |
Cerebrospinal fluid levels of alpha-synuclein measured using a poly-glutamic acid-modified gold nanoparticle-doped disposable neuro-biosensor system.
Topics: alpha-Synuclein; Antibodies, Immobilized; Biosensing Techniques; Dendrimers; Electrochemical Techniques; Electrodes; Gold; Humans; Metal Nanoparticles; Parkinson Disease; Polyglutamic Acid; Tin Compounds | 2019 |
Gold nanoclusters for Parkinson's disease treatment.
Topics: alpha-Synuclein; Animals; Antiparkinson Agents; Cysteine; Disease Models, Animal; Gold; Male; Mice, Inbred C57BL; Nanoparticles; Parkinson Disease; PC12 Cells; Rats | 2019 |
Influence of gold nanoparticles on the kinetics of α-synuclein aggregation.
Topics: alpha-Synuclein; Amyloid; Gold; Humans; Kinetics; Metal Nanoparticles; Parkinson Disease; Protein Structure, Secondary | 2013 |
Surface-enhanced Raman spectroscopy detection of dopamine by DNA Targeting amplification assay in Parkisons's model.
Topics: Animals; Biosensing Techniques; Corpus Striatum; Disease Models, Animal; DNA; Dopamine; Gold; Humans; Mice; Nucleic Acid Amplification Techniques; Parkinson Disease; Parkinsonian Disorders; Spectrum Analysis, Raman | 2015 |
Graphene oxide interfaces in serum based autoantibody quantification.
Topics: alpha-Synuclein; Autoantibodies; Biosensing Techniques; Cysteamine; Electrochemical Techniques; Gold; Graphite; Humans; Limit of Detection; Microelectrodes; Parkinson Disease | 2015 |
Unraveling the role of hydrogen peroxide in α-synuclein aggregation using an ultrasensitive nanoplasmonic probe.
Topics: alpha-Synuclein; Aniline Compounds; DNA; Gold; HEK293 Cells; Horseradish Peroxidase; Humans; Hydrogen Peroxide; Metal Nanoparticles; Oxidation-Reduction; Oxidative Stress; Parkinson Disease; Polymerization; Protein Aggregation, Pathological; Surface Plasmon Resonance | 2015 |
A photoelectrochemical immunosensor based on Au-doped TiO2 nanotube arrays for the detection of α-synuclein.
Topics: alpha-Synuclein; Antibodies, Immobilized; Aspergillus niger; Boron Compounds; Electrochemical Techniques; Glucose Oxidase; Gold; Humans; Immunoassay; Metal Nanoparticles; Nanotubes; Parkinson Disease; Titanium | 2010 |
[On the distribution of trace elements (manganese, copper, zinc, and gold) in serum and cerebrospinal fluid in epilepsy and parkinsonism].
Topics: Copper; Epilepsy; Gold; Humans; Manganese; Neutrons; Parkinson Disease; Radiometry; Trace Elements; Zinc | 1967 |